KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Shares Repurchased (2016 - 2026)

Medtronic (MDT) has disclosed Shares Repurchased for 13 consecutive years, with $105.0 million as the latest value for Q1 2026.

  • Quarterly Shares Repurchased fell 41.99% to $105.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $874.0 million through Jan 2026, down 80.95% year-over-year, with the annual reading at $3.2 billion for FY2025, 51.31% up from the prior year.
  • Shares Repurchased hit $105.0 million in Q1 2026 for Medtronic, down from $372.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $2.5 billion in Q3 2024 to a low of $71.0 million in Q1 2023.
  • Historically, Shares Repurchased has averaged $495.2 million across 5 years, with a median of $226.0 million in 2023.
  • Biggest five-year swings in Shares Repurchased: surged 4277.78% in 2022 and later plummeted 95.06% in 2025.
  • Year by year, Shares Repurchased stood at $141.0 million in 2022, then skyrocketed by 60.28% to $226.0 million in 2023, then increased by 27.43% to $288.0 million in 2024, then increased by 29.17% to $372.0 million in 2025, then plummeted by 71.77% to $105.0 million in 2026.
  • Business Quant data shows Shares Repurchased for MDT at $105.0 million in Q1 2026, $372.0 million in Q4 2025, and $123.0 million in Q3 2025.